Susan Hasty, Publisher
Table of Contents . . . June 24th, 1996Non-Subscriber - Summaries Only
Conference Coverage (IBC Protease Inhibitors) - HIV RNA Undetectable in >90% of Indinavir/AZT/3TC Recipients
Vaccine Safety - Flu Vaccine Increases Number of HIV-Infected Cells
AIDS Therapies (Delavirdine) - Drug Expanded Access Begins for People with HIV/AIDS
AIDS Therapies (Stavudine/Didanosine) - Combination Therapy Well Tolerated in Children with HIV
At-Risk Populations - High Risk of HIV Transmission in Mentally Ill, Homeless Drug Users Persists
Cachexia (Treatment) - Testosterone Dip May Predict Weight Loss in HIV
Emerging Infectious Diseases - Conference Session Highlights Worldwide Threat
Government (Policy) - Mandatory Names Reporting Bill Ab 2812 Defeat Announced
HIV Gene Therapy - HIV-2 Mediated Inhibition of HIV-1: Potential Gene Therapy Approach
HIV Testing - PERT Assay: A More Accurate Screen for Plasma RNA HIV-1
Herpes Zoster - Drug Rejected By FDA Advisory Committee
Industry News (Funding) - NIH Phase II Grant Received for HIV Therapeutics Development
Industry News (Joint Venture) - Agreement Signed To Develop and Commercialize HIV/AIDS Therapeutic
Infection Control - M. bovis-Related TB Rising with HIV Infection
International (Asia) - Cambodia Seeks Help for AIDS Patients
International (Asia) - Patients in India Ashamed To Tell Doctors They Have AIDS
International (Europe) - AIDS Primary Killer of Young, and Middle Aged Copenhagen Men
International (Europe) - Europe Urged To Curb Sexual Exploitation of Women
International (Europe) - United Nations AIDS Team Stays in Geneva
International (South Africa) - Brazil To Give Teens Junior-Sized Condoms
Mucosal Immunity - Intranasal Toxoplasma Subunit Vaccine Protects Against Brain Cysts
Occupational Exposure - New CDC Guidelines Established for HIV Exposure
Opportunistic Infections - Fluconazole Urged for Esophageal Symptoms in HIV Patients
Survival/Mortality - Young Age at HIV Seroconversion Equates with Longer Survival
Therapies (Alternative) - Transforming HIV with Thought Power
Transmission (HIV) - Oral Sex Added to Risk Behaviors for HIV
Epidemiology (Kaposi's Sarcoma) - "Fulminant Epidemic Kaposi's Sarcoma (EKS): Hallmark of AIDS in Zimbabwe."
Occupational Risk - "A Ten Year Study of Needlestick Injuries in a Community Teaching Hospital."
Therapy (Anti-Viral) - "Treating AIDS Patients With HIV-Specific Transfer Factor."
AIDS Therapies (Nonnucleoside Inhibitors) - "(Alkylamino)piperidine bis(heteroaryl)piperizine Analogs Are Potent, Broad-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors of Drug-Resistant Isolates of Human Immu
AIDS Therapies (Protease Inhibitors) - "Current Knowledge and Future Prospects for the Use of HIV Protease Inhibitors."
AIDS Therapies (Stavudine) - "Stavudine: A Review of Its Pharmacodynamic and Pharmacokinetic Properties and Clinical Potential in HIV Infection."
AIDS Therapies (Zidovudine) - "Evolution of Zidovudine Resistance-Associated Genotypes in Human Immunodeficiency Virus Type 1-Infected Patients."
Opportunistic Infections - "Nosocomial Colonization and Infection in Persons Infected with Human Immunodeficiency Virus."
Opportunistic Infections - "Patterns of Opportunistic Infections in Patients with HIV Infection."
Pediatrics (CNS Disease) - "Impairment of Expressive Behavior in Pediatric HIV-Infected Patients with Evidence of CNS Disease."
SIV Vaccines - "Patterns of Viral Replication Correlate with Outcome in Simian Immunodeficiency Virus (SIV)-Infected Macaques: Effect of Prior Immunization with a Trivalent SIV Vaccine in Modified Vaccinia Virus Anka
Virology - "Human Immunodeficiency Virus Type 1 Long Terminal Repeat Variants from 42 Patients Representing All Stages of Infection Display A Wide Range of Sequence Polymorphism and Transcription Activity."
Virology - "Natural Variation in HIV-1 Protease, gag p7 and p6, and Protease Cleavage Sites Within Gag/Pol Polyproteins: Amino Acid Substitutions in the Absence of Protease Inhibitors in Mothers and Chi
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.